Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares IssuedShort-Term Debt repayments
Ratios

United Therapeutics (UTHR) Short-Term Debt repayments (2019 - 2025)

United Therapeutics (UTHR) has disclosed Short-Term Debt repayments for 7 consecutive years, with $400.0 million as the latest value for Q2 2025.

  • Quarterly Short-Term Debt repayments rose 300.0% to $400.0 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $500.0 million through Dec 2025, up 25.0% year-over-year, with the annual reading at $500.0 million for FY2025, 25.0% up from the prior year.
  • Short-Term Debt repayments hit $400.0 million in Q2 2025 for United Therapeutics, up from $100.0 million in the prior quarter.
  • In the past five years, Short-Term Debt repayments ranged from a high of $800.0 million in Q1 2022 to a low of $100.0 million in Q4 2023.
  • Historically, Short-Term Debt repayments has averaged $225.0 million across 4 years, with a median of $100.0 million in 2023.
  • Biggest five-year swings in Short-Term Debt repayments: changed 0.0% in 2024 and later soared 300.0% in 2025.
  • Year by year, Short-Term Debt repayments stood at $800.0 million in 2022, then crashed by 87.5% to $100.0 million in 2023, then changed by 0.0% to $100.0 million in 2024, then skyrocketed by 300.0% to $400.0 million in 2025.
  • Business Quant data shows Short-Term Debt repayments for UTHR at $400.0 million in Q2 2025, $100.0 million in Q1 2025, and $100.0 million in Q4 2024.